Agreement signedAgreed 17 Jan 2023

Leap Therapeutics, Inc. /
Flame Biosciences, Inc.

Leap Therapeutics, Inc. agrees to buy Flame Biosciences, Inc.

Terms
Not stated
Stage
Agreement signed
Buy side: Leap Therapeutics, Inc.
Buy sideLeap Therapeutics, Inc.
Target: Flame Biosciences, Inc.
TargetFlame Biosciences, Inc.
Source · 17 Jan 2023
Buy side: Leap Therapeutics, Inc.
Buy sideLeap Therapeutics, Inc.
Target: Flame Biosciences, Inc.
TargetFlame Biosciences, Inc.
01 / BuyerLeap Therapeutics, Inc.
02 / TargetFlame Biosciences, Inc.
01

What happened

Leap Therapeutics, Inc. agreed to acquire Flame Biosciences, Inc., according to a filing dated March 24, 2023.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Leap Therapeutics, Inc. agrees to buy Flame Biosciences, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Announced

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.